CX Abstract sessions and Posters

CX Abstract Board: Richard Gibbs, Ian Loftus, Colin Bicknell, Alun Davies, Paul Hayes and Robert Hinchliffe

 For the second year running, the Charing Cross Symposium showcased the research of upcoming leaders in the field at the CX Abstract Sessions. The CX Abstract Board and CX Programme Organising Board selected over 130 abstracts for presentation at this year’s event.

Throughout the four days of the Symposium, the abstract presentations were divided into six themed sessions ‒ peripheral arterial, abdominal aortic, venous, carotid, thoracic aortic, and vascular access ‒ and took place in the CX Learning Centres. In addition to abstracts, the CX Abstract Board selected the posters that were displayed in the Exhibition Hall (in front of the Grey Learning Centre). 

The abstracts selected for presentation were included in the first CX Abstract Book. The best abstract presentation in each category (senior and junior) was awarded £1,000 and a diploma for best presentation. The winners and certificate of merit holders have also been invited to suggest a topic for presentation at the Charing Cross Symposium in 2016.

The CX Abstract Sessions are a platform designed to spot and promote new talent. It provides an opportunity to recognise upcoming leaders in the vascular and endovascular field who could become part of the invited CX Faculty in the future.


jQuery UI Accordion - Default functionality

Tuesday 28 April 2015 - Peripheral Arterial
Olympia Room

Peripheral Presentations - Part One
Chairing: Robert Hinchliffe, London, United Kingdom
Chairing: Alun Davies, Imperial College, London, United Kingdom
08:30-08:35 Effectiveness of preoperative diastolic ratios and MRA-derived runoff classification in predicting early graft failure in distal bypass surgery (S)
Abdullah Jibawi, Chertsey, United Kingdom
08:35-08:40 Discussion 08:40-08:45 Impact of vessel calcification and lesion length on target lesion revascularisation following bare metal and drug-eluting stent placement in infrapopliteal lesions (S)
Thomas Zeller, Bad Krozingen, Germany
08:45-08:50 Discussion 08:50-08:55 Femoropopliteal artery stenting with the Eluvia drug-eluting stent: primary endpoint results of the MAJESTIC trial (S)
Stefan Mueller-Huelsbeck, Flensburg, Germany
08:55-09:00 Discussion 09:00-09:05 Factors predicting failure or success in occlusive superficial femoral artery disease treated minimally invasive with covered stents (T)
Floris Poelmann, Groningen, Netherlands
09:05-09:10 Discussion 09:10-09:15 Superficial femoral artery occlusive disease: open and endovascular revascularisation based on morphology and length of lesions (TBA)
Rosario Tringale, Catania, Italy
09:15-09:20 Discussion 09:20-09:25 Treatment of popliteal artery aneurysms by arterial cryopreserved homografts: results after eight-year follow-up (S)
Gian Franco Veraldi, Verona, Italy
09:25-09:30 Discussion 09:30-09:35 Midterm results in treating femoropopliteal occlusive disease with biomimetic helical interwoven nitinol stents (S)
Yiu Che Chan, Hong Kong, Hong Kong
09:35-09:40 Discussion

Tuesday 28 April 2015 - Abdominal Aortic
London Room

Abdominal Aortic Presentations - Part One
Chairing: Ian Loftus, London, United Kingdom
Chairing: Paul Hayes, Cambridge, United Kingdom
09:00-09:05 Self-reported fitness of ASA 3 patients undergoing EVAR predicts patient survival (S)
Robert Fitridge, Woodville South, Australia
09:05-09:10 Discussion 09:10-09:15 Changes in workload and service demand following centralisation of aortic aneurysm surgery: a quantitative model (S)
Abdullah Jibawi, Chertsey, United Kingdom
09:15-09:20 Discussion 09:20-09:25 Predicting outcomes after open and endovascular aneurysm repair using the SGVI-score (S)
Jorg de Bruin, London, United Kingdom
09:25-09:30 Discussion 09:30-09:35 CXCR4 activity in abdominal aortic aneurysm wall (VS)
Fadwa Tanios, Munich, Germany
09:35-09:40 Discussion 09:40-09:45 Cardiovascular risk prevention in patients with aortic aneurysms in the United Kingdom: clinical lessons from the analysis of primary care records (T)
Alan Karthikesalingam, London, United Kingdom
09:45-09:50 Discussion 09:50-09:55 A ruptured abdominal aortic aneurysm requiring preoperative cardiopulmonary resuscitation is not necessarily lethal (T)
Yannick 't Mannetje, Eindhoven, Netherlands
09:55-10:00 Discussion COFFEE 10:30-10:35 The implications of measuring abdominal aortic aneurysm internal wall diameter: is it safe? (T)
Helen Suttenwood, Twickenham, United Kingdom
10:35-10:40 Discussion 10:40-10:45 Abdominal aortic aneurysms in smokers rupture earlier than in non-smokers (T)
Matti Laine, Helsinki, Finland
10:45-10:50 Discussion 10:50-10:55 Shared decision making in vascular surgery (T)
Katrien Santema, Amsterdam, Netherlands
10:55-11:00 Discussion 11:00-11:05 The national abdominal aortic aneurysm screening programme: evidence for review of current screening protocols (T)
Ruth Benson, London, United Kingdom
11:05-11:10 Discussion 11:10-11:15 Mortality from ruptured abdominal aortic aneurysm is associated with hospital structures and processes (T)
Baris Ata Ozdemir, London, United Kingdom
11:15-11:20 Discussion 11:20-11:25 Predictors for the perioperative outcome for treatment of abdominal aortic aneurysms: an analysis of the quality assurance registry of the German Vascular Society (DGG) with focus on annual caseload (T)
Matthias Trenner, Munich, Germany
11:25-11:30 Discussion 11:30-11:35 AAA volume is a better predictor of growth than maximum diameter and correlates with an increasing rupture risk (T)
Joy Roy, Stockholm, Sweden
11:35-11:40 Discussion 11:40-11:45 Ten-year experience with management of aortoiliac aneurysms by using retrograde endovascular internal iliac artery preservation (S)
Bernardo Massiere, Rio de Janeiro, Brazil
11:45-11:50 Discussion LUNCH

Tuesday 28 April 2015 - Venous
London Room

Venous Presentations (1)
Chairing: Ian Franklin, Imperial College, London, United Kingdom
Chairing: Mark Whiteley, Guildford, United Kingdom
13:30-13:35 Effect of number of passes and gauge of needle on the longevity of Tessari foam for sclerotherapy (MS)
Alice Whiteley, Guildford, United Kingdom
13:35-13:40 Discussion 13:40-13:45 Radiofrequency ablation of the great saphenous vein: influence of vein diameter and obesity on clinical outcome. A prospective evaluation of 106 procedures (s)
David Horn, Brussels, Belgium
13:45-13:50 Discussion 13:50-13:55 Modelling vein wall thickness under tumescence and the implications for endovenous thermoablation devices (VS)
Timothy Fernandez-Hart, Guildford, United Kingdom
13:55-14:00 Discussion 14:00-14:05 The role of intraoperative transvaginal duplex ultrasound during pelvic vein embolisation (S)
Previn Diwakar, Guildford, United Kingdom
14:05-14:10 Discussion 14:10-14:15 Efficacy and results of transdermal thermocoagulation modality in the treatment of reticular and telengiectasic leg veins: 10 years single centre experience (S)
Ufuk Demirkilic, ANKARA, Turkey
14:15-14:20 Discussion 14:20-14:25 Two-year two-ring radial fibre experience in the endovenous laser ablation of varicose veins (S)
Ufuk Demirkilic, ANKARA, Turkey
14:25-14:30 Discussion 14:30-14:35 Comparison of CR30i fibre vs. sclerotherapy with higher concentration of polidocanol in the treatment of reticular veins (S)
Ufuk Demirkilic, ANKARA, Turkey
14:35-14:40 Discussion 14:40-14:45 Implementation of a new two-ring radial fibre combined with 1470nm diode laser as promising standard treatment for great saphenous vein insufficiency of more than 8mm and evaluation of the wellbeing and of your quality of life (QoL) by using the VCSS and CIVIQ questionnaires (VS)
Andreas Fiebig, Kiel, Germany
14:45-14:50 Discussion 14:50-14:55 First clinical results of endovenous laser therapy (ELT) for the occlusion of incompetent saphenous veins using Tm-laser (1940nm) and radial light application (S)
Claus-Georg Schmedt, Schwabisch Hall, Germany
14:55-15:00 Discussion 15:00-15:05 Mid-term results of the triple therapy for Pagette-Schroetter syndrome are promising (S)
Osman Mahmoud, ESPOO, Finland
15:05-15:10 Discussion 15:10-15:15 Intraprocedural pain score in a randomised controlled trial comparing mechanochemical ablation to radiofrequency ablation: the multicentre VenefitTM versus ClariVein® for varicose veins (VVCVV) trial (T)
Roshan Bootun, London, United Kingdom
15:15-15:20 Discussion 15:20-15:25 Quality-of-life assessment in patients after endovenous laser therapy and conventional surgery using VCSS (Venous Clinical Severity Score) (T)
Robert Vlachovsky, Brno, Czech Republic
15:25-15:30 Discussion TEAVenous Presentations (2)
Chairing: Stephen Black, London, United Kingdom
Chairing: Alun Davies, Imperial College, London, United Kingdom
16:00-16:05 Neuromuscular electrical stimulation for thromboprophylaxis: a systematic review (T)
Shahab Hajibandeh, Liverpool, United Kingdom
16:05-16:10 Discussion 16:10-16:15 Is pharmacomechanical catheter-directed thrombolysis indicated in acute deep venous thrombosis with chronic inferior vena occlusion? (S)
Zoltan Szeberin, Budapest, Hungary
16:15-16:20 Discussion 16:20-16:25 Exploiting percutaneous transluminal angioplasty during the insertion of central venous catheter for haemodialysis in difficult cases (S)
Mohamed El-Maadawy, Cairo, Egypt
16:25-16:30 Discussion 16:30-16:35 Recanalisation of portal venous thrombosis using a mechanical rotational thrombectomy system (S)
Thomas Heller, Rostock, Germany
16:35-16:40 Discussion 16:40-16:45 Catheter-directed thrombolysis versus pharmacomechanical thrombectomy in treatment of upper deep vein thrombosis: cost-effectiveness analysis (T)
Osman Mahmoud, ESPOO, Finland
16:45-16:50 Discussion 16:50-16:55 Novel oral anticoagulants and venous thromboembolism – should we slow the pace? (T)
Tamer El Nakhal, Alexandria, Egypt
16:55-17:00 Discussion 17:00-17:05 Excisional surgery for morbid lymphoedema of the leg: modified technique (S)
Yasser Elkiran, Mansoura, Egypt
17:05-17:10 Discussion

Wednesday 29 April 2015 - Thoracic Aortic
Olympia Room

Thoracic Aortic (inc. Aortic Arch/Juxta-renal Aortic) (1)
Chairing: Ian Loftus, London, United Kingdom
Chairing: Richard Gibbs, Imperial College, London, United Kingdom
14:00-14:05 Penetrating aortic ulceration in chest (S)
Malgorzata Szostek, Warsaw, Poland
14:05-14:10 Discussion 14:10-14:15 Acute type B aortic dissection is a life threatening disease-results from a consecutive single centre study (T)
Benedikt Reutersberg, Munich, Germany
14:15-14:20 Discussion 14:20-14:25 Retroflection of stent grafts during thoracic aneurysm repair should be considered as a failure mode for late type Ia endoleak (T)
Fiona Rohlffs, Hamburg, Germany
14:25-14:30 Discussion 14:30-14:35 Statin therapy significantly reduces rate of degenerative thoracic aortic aneurysm growth (MS)
Naomi Oraha, Imperial College, London, United Kingdom
14:35-14:40 Discussion 14:40-14:45 Outcomes of patients with ruptured suprarenal aneurysm or dissection transferred to a specialist centre: implications for the organisation of supraregional vascular services in the UK (T)
Nung Rudarakanchana, Imperial College, London, United Kingdom
14:45-14:50 Discussion 14:50-14:55 Predicting mid-term all-cause survival in patients undergoing thoracic endovascular aneurysm repair (T)
Benjamin Patterson, Surrey, United Kingdom
14:55-15:00 Discussion 15:00-15:05 Risk assessment and implications of postoperative cognitive decline after aortic aneurysm repair (T)
Ruth Benson, London, United Kingdom
15:05-15:10 Discussion 15:10-15:15 Systematic review of multilayer flow modulator in the management of complex aortic aneurysms and dissections (VS)
Ala Elhelali, Galway, Ireland
15:15-15:20 Discussion 15:20-15:25 Early experience with the Zenith Ascend stent graft (S)
Nikolaos Tsilimparis, Hamburg, Germany
15:25-15:30 Discussion TEA Thoracic Aortic (inc. Aortic Arch/Juxta-renal Aortic) (2)
Chairing: Stéphan Haulon, Lille, France
Chairing: Richard Gibbs, Imperial College, London, United Kingdom
16:00-16:05 Spinal protection during management of thoracic aortic pathologies-recent experiences with open repair and endovascular stent grafting (T)
Ajay Savlania, Trivandrum, India
16:05-16:10 Discussion 16:10-16:15 Utility of balloon occlusion of left subclavian artery during hybrid arch TEVAR (S)
Hitoshi Matsuda, Himeji, Japan
16:15-16:20 Discussion 16:20-16:25 Pre-emptive bypass with type A repair: future proofing in complex dissections (S)
Thodur Vasudevan, Hamilton, New Zealand
16:25-16:30 Discussion 16:30-16:35 Multilayer flow modulator devices in the management of complex aortic arch aneurysms – report of first six cases (VS)
Florian Stefanov, Galway, Ireland
16:35-16:40 Discussion 16:40-16:45 Floating thrombus in the aortic arch as a cause of systemic emboli (T)
Salome Weiss, Bern, Switzerland
16:45-16:50 Discussion 16:50-16:55 Parallel stent-grafting and physician modified endografts for high-risk pararenal aortic aneurysm repair: should they replace open surgery? (S)
Murray L Shames, Tampa, FL, United States
16:55-17:00 Discussion 17:00-17:05 The endovascular sealing device in combination with parallel grafts to treat juxtarenal aneurysms: a case series (S)
Jorg de Bruin, London, United Kingdom
17:05-17:10 Discussion

Wednesday 29 April 2015 - Carotid
London Room

Carotid Presentations
Chairing: Ross Naylor, Leicester, United Kingdom
Chairing: Paul Hayes, Cambridge, United Kingdom
10:30-10:35 The contralateral internal carotid artery stenosis improves carotid surgery risk stratification (T)
Jelena Basic, Vienna, Austria
10:35-10:40 Discussion 10:40-10:45 The ratio of apolipoprotein A-II/B improves lipoprotein-associated risk prediction of postoperative survival in carotid surgery (T)
Nikolaus Duschek, Vienna, Austria
10:45-10:50 Discussion 10:50-10:55 Pre-CABG carotid intervention: just don't do it (T)
Mohammed Ashrafi, Manchester, United Kingdom
10:55-11:00 Discussion 11:00-11:05 Influence of time from last symptomatic event to carotid endarterectomy on the combined stroke and mortality rate in patients with symptomatic carotid stenosis (T)
Pavlos Tsantilas, Munich, Germany
11:05-11:10 Discussion 11:10-11:15 Early outcomes after carotid endarterectomy in end-stage renal disease patients (S)
Mahmoud Malas, Baltimore, MD, United States
11:15-11:20 Discussion 11:20-11:25 Carotid endarterectomy following thrombolysis for acute stroke: an early and safe prevention from new ischaemic events (T)
Gladiol Zenunaj, Ferrara, Italy
11:25-11:30 Discussion 11:30-11:35 Mechanism of post-carotid angioplasty hypotension (S)
Michael Dahn, Farmington, CT, United States
11:35-11:40 Discussion LUNCH

Wednesday 29 April 2015 - Peripheral Arterial
London Room

Peripheral Presentations - Part Two (1)
Chairing: Cliff Shearman, Southampton, United Kingdom
Chairing: Alun Davies, Imperial College, London, United Kingdom
13:30-13:35 Use of conical balloons to recanalise occluded below-the-knee arteries in diabetic patients with critical limb ischaemia (S)
Nicola Troisi, Florence, Italy
13:35-13:40 Discussion 13:40-13:45 Reappraisal of autologous vein bypass to the ankle and foot for critical limb ischaemia – results of a contemporary single-centre series (S)
Achim Neufang, Wiesbaden, Germany
13:45-13:50 Discussion 13:50-13:55 Emergency implantation of covered stent in the management of arterial injuries (S)
Maria Antonella Ruffino, Turin, Italy
13:55-14:00 Discussion 14:00-14:05 Heparin-bonded dual-component stent implantation in de novo stenotic and occlusive popliteal artery lesions: one-year results (S)
Ulf Teichgraeber, Jena, Germany
14:05-14:10 Discussion 14:10-14:15 Recanalisation and balloon angioplasty of the tibial arteries is a method of choice in the patients with diabetic foot (T)
Surat Temirov, Tashkent, Uzbekistan
14:15-14:20 Discussion 14:20-14:25 A 30-year experience with surgical management of popliteal artery aneurysms (S)
Walter Dorigo, Florence, Italy
14:25-14:30 Discussion 14:30-14:35 Indocyanine green angiography as a quality control during peripheral revascularisation (T)
Matteo Bossi, Varese, Italy
14:35-14:40 Discussion 14:40-14:45 Bypass remains the gold standard option for limb salvage in critical limb ischaemia in the era of dominant endovascular interventions (S)
Mahmoud Malas, Baltimore, MD, United States
14:45-14:50 Discussion 14:50-14:55 The feasibility of angiosome-targeted endovascular treatment in patients with critical limb ischaemia and foot ulcer (T)
Kristyna Spillerova, Helsinki, Finland
14:55-15:00 Discussion 15:00-15:05 Preliminary results on the use of drug-eluting balloons in peripheral vascular restenosis (T)
Patrick Bjorkman, Helsinki, Finland
15:05-15:10 Discussion 15:10-15:15 Influence of revascularisation modality on level of lower extremity amputation in England (T)
Naseer Ahmad, Liverpool, United Kingdom
15:15-15:20 Discussion TEA Peripheral Presentations - Part Two (2)
Chairing: Robert Hinchliffe, London, United Kingdom
Chairing: Alun Davies, Imperial College, London, United Kingdom
16:00-16:05 Hybrid approach as a valid alternative to the traditional surgery for the treatment of iliac-femoral disease (T)
Gladiol Zenunaj, Ferrara, Italy
16:05-16:10 Discussion 16:10-16:15 Proposed classification of hybrid endovascular and open surgical revascularisation for peripheral arterial disease – Hybrid Intervention for Lower Extremity Revascularisation (HILER) (T)
Yiewfah Fong, Singapore
16:15-16:20 Discussion 16:20-16:25 Endovascular surgery management of percutaneous transfemoral access to minimise vascular complications related to transcatheter aortic valve implantation (T)
Fabien Lareyre, Monaco, France
16:25-16:30 Discussion 16:30-16:35 Determinants and outcomes of reinterventions following endovascular treatment of peripheral arterial disease (S)
Raffaele Pulli, Firenze, Italy
16:35-16:40 Discussion 16:40-16:45 A negative pressure dressing for reduction of surgical site infections in the groin (S)
Michael Engelhardt, Ulm, Germany
16:45-16:50 Discussion 16:50-16:55 Salvage of chronically occluded prosthetic grafts by hybrid procedure for critical limb ischaemia (T)
Hemil Patel, Bangalore, India
16:55-17:00 Discussion 17:00-17:05 Swedish drug elution trial in peripheral arterial disease (SWEDEPAD) (S)
Marten Falkenberg, Gothenburg, Sweden
17:05-17:10 Discussion 17:10-17:15 Proposal for a new model for the study of patient-perceived quality of life in the surgical treatment of peripheral arterial occlusive disease: the SPADI (Surgical Peripheral Artery Disease Interview) questionnaire (T)
Elena Giacomelli, Florence, Italy
17:15-17:20 Discussion 17:20-17:25 The methodological and reporting quality of randomised control trials in vascular surgery: are we improving? (T)
Patrick Green, Liverpool, United Kingdom
17:25-17:30 Discussion 17:30-17:35 Major lower limb amputation in England 2003–2013. Gender and regional inequalities remain despite overall falling levels (T)
Naseer Ahmad, Stockport, United Kingdom
17:35-17:40 Discussion 17:40-17:45 Critical low limb ischaemia in individuals with an abdominal aortic calcification (T)
Vladimir Zelinskiy, Saint Petersburg,
17:45-17:50 Discussion 17:50-17:55 Epidemiology and outcomes of 655 diabetic foot patients in a Brazilian university hospital (T)
Rafael Costa, Belo Horizonte, Brazil
17:55-18:00 Discussion 18:00-18:05 Does matrix Gla protein (MGP) play a role in diabetics with peripheral vascular disease? (T)
Abigail Morbi, Southampton, United Kingdom
18:05-18:10 Discussion

Thursday 30 April 2015 - Abdominal Aortic
Olympia Room

Abdominal Aortic Presentations - Part Two (1)
Chairing: Ian Loftus, London, United Kingdom
Chairing: Richard Gibbs, Imperial College, London, United Kingdom
14:00-14:05 Optimal surgical treatment strategy for aortic pseudoaneurysm in Behcet's disease: endovascular repair or open surgery? (S)
Chenyang Shen, Beijing, China
14:05-14:10 Discussion 14:10-14:15 The rationale in the treatment of visceral artery aneurysms (S)
Roberto Gattuso, Rome, Italy
14:15-14:20 Discussion 14:20-14:25 Aneurysm sac embolisation during endovascular aneurysm repair in patients at high risk for endoleak II: results of a prospective single-centre randomised study (S)
Michele Antonello, Padua, Italy
14:25-14:30 Discussion 14:30-14:35 Computational analysis of the forces involved in the proximal fixation of stent-grafts used for endovascular abdominal aortic aneurysm repair (S)
Saroj Das, Imperial College, London, United Kingdom
14:35-14:40 Discussion 14:40-14:45 First experience of endovascular sealing (Nellix) in a ruptured abdominal aortic aneurysm: a case report of an elderly patient (S)
Gioachino Coppi, Modena, Italy
14:45-14:50 Discussion 14:50-14:55 Intraoperative aneurysm sac embolisation with fibrin glue (Tiseel) during endovascular aneurysm repair in the prevention of type II endoleak: a single-centre experience (T)
Luigi Iazzolino, Parma, Italy
14:55-15:00 Discussion 15:00-15:05 Early clinical experience after 70 endovascular aortic sealing procedures for abdominal aortic aneurysm repair: first steps and a few chimneys further (T)
Sebastian Zerwes, Augsburg, Germany
15:05-15:10 Discussion 15:10-15:15 Emergency EVAR first approach following standardised rupture protocol achieves lower perioperative mortality: experience from Hong Kong East Cluster (S)
Skyi Yin Chun Pang, Hong Kong, Hong Kong
15:15-15:20 Discussion TEA Abdominal Aortic Presentations - Part Two (2)
Chairing: Colin Bicknell, Imperial College, London, United Kingdom
Chairing: Richard Gibbs, Imperial College, London, United Kingdom
16:00-16:05 Is it possible to improve monitoring methods in elective aortic aneurysm surgery using industrial methodologies: a CUSUM (SPRT) real-time feasibility study using anonymised UK national vascular database (S)
Abdullah Jibawi, Chertsey, United Kingdom
16:05-16:10 Discussion 16:10-16:15 Haemodynamic stability and endovascular treatment reduced mortality in ruptured abdominal aneurysms: results from 68 consecutive patients (S)
Alberto Froio, Monza, Italy
16:15-16:20 Discussion 16:20-16:25 Selective management strategies for proximal EVAR failure: a 12-year experience (S)
Murray L Shames, Tampa, FL, United States
16:25-16:30 Discussion 16:30-16:35 Post-implantation syndrome following endovascular abdominal aortic aneurysm repair: analysis of predictive factors of occurrence and evaluation of its role on early and late outcomes (S)
Giustino Marcucci, Rome, Italy
16:35-16:40 Discussion 16:40-16:45 The impact of an "enhanced recovery after surgery" programme in elective retroperitoneal abdominal aortic aneurysm repair (S)
Francesco G Mascoli, Ferrara, Italy
16:45-16:50 Discussion 16:50-16:55 International validation of a risk score for complications and reinterventions after endovascular aneurysm repair (EVAR): an evidence base for endograft surveillance (T)
Alan Karthikesalingam, London, United Kingdom
16:55-17:00 Discussion 17:00-17:05 Outcomes of persistent intraoperative type Ia endoleak following standard endovascular aneurysm repair (T)
George Antoniou, Liverpool, United Kingdom
17:05-17:10 Discussion 17:10-17:15 The short- and long-term impact of endovascular aneurysm repair on renal function (T)
Athanasios Saratzis, Leicester, United Kingdom
17:15-17:20 Discussion 17:20-17:25 The safety, feasibility and utility of C-arm cone beam computerised tomography with XpertCT post-EVAR (S)
Patrick Chong, Frimley, United Kingdom
17:25-17:30 Discussion 17:30-17:35 Role of a free DICOM-viewer for MAC for pre-operative planning for endovascular repair of abdominal aortic aneurysms (S)
Alberto Froio, Monza, Italy
17:35-17:40 Discussion 17:40-17:45 The role of FDG PET-CT in the diagnostic work up and monitoring of prosthetic vascular graft infections (T)
Anuja Mitra, London, United Kingdom
17:45-17:50 Discussion

Tuesday 28 April 2015 – Friday 1 May - CX Posters
Exhibition Hall

Carotid artery involvement in head and neck cancer: a surgical challenge (T)
Gonçalo Rodrigues, Lisbon, Portugal
The collateral communication between peripheral arteries and segmental arteries after the hybrid repair of thoracoabdominal aneurysm (S)
Takayuki Shijo, Osaka, Japan
Preoperative clinical and anatomical factors associated with 12-month survival after endovascular aneurysm repair (S)
Robert Fitridge, Woodville South, Australia
Abdominal aortic aneurysm screening in men aged 60 years and over: a pilot study from Ankara (S)
Ugur Bengisun, Ankara, Turkey
Midterm results following endovascular aortic aneurysm repair in severe neck angulation using Zenith and Endurant stent graft (S)
Khamin Chinsakchai, Pathumthani, Thailand
Endovascular aneurysm sealing for the treatment of ruptured abdominal aortic aneurysms (S)
Jorg de Bruin, London, United Kingdom
Growth prediction of abdominal aortic aneurysms by combining CTA follow-up data with biomechanical simulations (S)
Thomas Christian Gasser, Stockholm, Sweden
Type I endoleak after endovascular abdominal aortic aneurysm repair: long-term incidence, outcomes and subsequent management (T)
Athanasios Saratzis, Leicester, United Kingdom
The association of simple renal cysts with abdominal aortic aneurysms and their impact on renal function after endovascular aneurysm repair (T)
Konstantinos Spanos, Larissa, Greece
Transthoracic echo as a predictor of long-term survival after endovascular aortic aneurysm surgery (T)
Sandeep Bahia, London, United Kingdom
A clinico-pathological study of inflammatory and atherosclerotic abdominal aortic aneurysms (VS)
Ala Elhelali, Galway, Ireland
The first systematic review of reported patient safety events in vascular aortic practice (T)
Anthony Dean Godfrey, London, United Kingdom
Extracellular signal-related kinase as compensatory signalling peptide in abdominal aortic aneurysm development (T)
Menno Groeneveld, Amsterdam, Netherlands
Screening for abdominal aortic aneurysm in patients undergoing echocardiography (T)
Baris Ata Ozdemir, London, United Kingdom
Surveillance not intervention: infrarenal endovascular abdominal aortic aneurysm repair endoleaks are mostly inconsequential and can be managed expectantly without intervention (T)
Matthew Reeds, Harrow, United Kingdom
Role of endothelin-1 and effects of its antagonist bosentan in diabetic peripheral arterial disease (S)
Antonio Martin-Conejero, Madrid, Spain
Diabetic foot infection: early endovascular revascularisation followed by surgical treatment saves tissue (S)
Nicola Troisi, Florence, Italy
Clinical results of percutaneous transluminal angioplasty for thromboangiitis obliterans in arteries above the knee (S)
Junmin Bao, Shanghai, China
Efficacy and safety of the cardiva catalyst closure device in antegrade and retrograde femoral arterial punctures (S)
Nelson Menezes, Brooklyn, United States
Incidence of diabetic foot disorders in patients with diabetes in Jeddah, Saudi Arabia (S)
Hasan Ali Alzahrani, Jeddah, Saudi Arabia
An 'Amputation Care Pathway' reduces morbidity and mortality: a district general hospital model (T)
Jason Lewis, London, United Kingdom
Availability of supervised exercise programmes for patients with peripheral arterial disease (T)
Adarsh Babber, London, United Kingdom
Epidemiology, risk factors and outcomes of 887 patients with chronic critical limb ischaemia in a tertiary university hospital in Brazil (T)
Rafael Costa, Belo Horizonte, Brazil
Understanding patient acceptance of risk with treatment options for intermittent claudication (T)
Abigail Morbi, Southampton, United Kingdom